Author
Listed:
- Marcos Galasso
(Toronto General Research Institute, University Health Network)
- Jordan J. Feld
(University Health Network, Toronto General Hospital)
- Yui Watanabe
(Toronto General Research Institute, University Health Network)
- Mauricio Pipkin
(Toronto General Research Institute, University Health Network)
- Cara Summers
(Toronto General Research Institute, University Health Network)
- Aadil Ali
(Toronto General Research Institute, University Health Network)
- Robert Qaqish
(Toronto General Research Institute, University Health Network)
- Manyin Chen
(Toronto General Research Institute, University Health Network)
- Rafaela V. P. Ribeiro
(Toronto General Research Institute, University Health Network)
- Khaled Ramadan
(Toronto General Research Institute, University Health Network)
- Layla Pires
(Toronto General Research Institute, University Health Network)
- Vanderlei S. Bagnato
(São Carlos Institute of Physics, University of São Paulo Brazil)
- Cristina Kurachi
(São Carlos Institute of Physics, University of São Paulo Brazil)
- Vera Cherepanov
(University Health Network, Toronto General Hospital)
- Gray Moonen
(Toronto General Research Institute, University Health Network)
- Anajara Gazzalle
(Toronto General Research Institute, University Health Network)
- Thomas K. Waddell
(Toronto General Research Institute, University Health Network)
- Mingyao Liu
(Toronto General Research Institute, University Health Network)
- Shaf Keshavjee
(Toronto General Research Institute, University Health Network)
- Brian C. Wilson
(University of Toronto)
- Atul Humar
(University Health Network)
- Marcelo Cypel
(Toronto General Research Institute, University Health Network
University Health Network)
Abstract
Availability of organs is a limiting factor for lung transplantation, leading to substantial mortality rates on the wait list. Use of organs from donors with transmissible viral infections, such as hepatitis C virus (HCV), would increase organ donation, but these organs are generally not offered for transplantation due to a high risk of transmission. Here, we develop a method for treatment of HCV-infected human donor lungs that prevents HCV transmission. Physical viral clearance in combination with germicidal light-based therapies during normothermic ex-vivo Lung Perfusion (EVLP), a method for assessment and treatment of injured donor lungs, inactivates HCV virus in a short period of time. Such treatment is shown to be safe using a large animal EVLP-to-lung transplantation model. This strategy of treating viral infection in a donor organ during preservation could significantly increase the availability of organs for transplantation and encourages further clinical development.
Suggested Citation
Marcos Galasso & Jordan J. Feld & Yui Watanabe & Mauricio Pipkin & Cara Summers & Aadil Ali & Robert Qaqish & Manyin Chen & Rafaela V. P. Ribeiro & Khaled Ramadan & Layla Pires & Vanderlei S. Bagnato , 2019.
"Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion,"
Nature Communications, Nature, vol. 10(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-08261-z
DOI: 10.1038/s41467-018-08261-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-08261-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.